CIDRAP newsletters options
Symptomatic COVID-19 cases are responsible for more viral transmission than asymptomatic infections, suggests an updated systematic review and meta-analysis of 130 studies published yesterday in PLOS Medicine.
Yesterday the US Department of Agriculture's National Institute of Food and Agriculture (USDA NIFA) announced an investment of more than $5 million, spread across nine projects, to mitigate antimicrobial resistance (AMR) across the food chain.
Weekly prescriptions for oral COVID-19 antivirals rose from about 27,000 to more than 182,000 in 7 weeks.
"The risk of exposure is not limited to any one particular group," CDC director says, adding that the disease doesn't care about borders.
A letter yesterday in the New England Journal of Medicine (NEJM) from Centers for Disease Control and Prevention scientists shows homologous (same-vaccine) boosting for Johnson & Johnson (J&J) vaccine recipients was significantly less effective than mix-and-match booster doses when the Omicron strain was predominant in the United States.
Though given to only 1 patient, tecovirimat was tied to a shorter illness and signs of shorter viral shedding.
Two global regions that saw recent increases in infections are now seeing downturns, but the US reports the most new cases and deaths.
Cases in Europe have risen to 118, and the UK has now confirmed 78 monkeypox infections.
UK-based charitable foundation Wellcome is funding and co-developing a new project aimed at helping countries with limited resources make the best use of antimicrobial resistance (AMR) surveillance data to optimize antibiotic use and help reduce the spread of drug-resistant pathogens.
Transmission of COVID-19 was significantly lower, and viable virus was detected for a shorter period, in fully vaccinated patients and staff isolated at a South Korean hospital than in their partially vaccinated and unvaccinated counterparts, finds a study published yesterday in JAMA Network Open.
The agency also alerts clinicians about COVID-19 rebound after Paxlovid.
COVID-19 patients had persistent signs of heart and lung involvement, inflammation, and clotting.
California and Washington state report their first cases, as CDC experts advise on what doctors should be alert for.
Flu levels are up sharply in some Australian states, putting pressure on healthcare systems that are also coping with ongoing COVID-19 activity and prompting more efforts to get more people vaccinated against flu.
A study from Israel published today in BMJ shows that the effectiveness of a fourth dose of Pfizer-BioNTech's mRNA COVID vaccine waned faster than a third dose in adults ages 60 and older.
A plant closing could affect 5 essential generic drugs for which Teva had an over 15% market share.
FDA advisers will meet in a few weeks to discuss emergency use of 3 doses.
Compared with Omicron, MIS-C rate was 14 times higher amid Alpha and 13 times higher during Delta.
The CDC says many patients have a distinctive monkeypox rash around their genitals, and UK officials report 36 new infections.
While COVID-19–related thyroid inflammation usually resolves shortly after the acute illness, about half of participants in a study presented today at the 24th European Congress of Endocrinology still had thyroid abnormalities a year later. The congress is being held May 21 to 24 in Milan, Italy.
